Utah Hockey Star Lawson Crouse Fails Drug Test, Jeopardizing Lucrative Contract
Salt Lake City, UT — Utah Hockey Club forward Lawson Crouse is facing major repercussions after reportedly failing a drug test, putting his lucrative multi-year contract at risk. The 27-year-old power forward, known for his physical play and scoring ability, violated the NHL/NHLPA Performance Enhancing Substances Program, according to league sources.
Crouse, who signed a five-year, $25 million extension in 2023, could now face suspension, fines, or even contract termination depending on the severity of the violation. The NHL has a strict anti-doping policy, and first-time offenders typically receive a 20-game suspension without pay, along with mandatory substance abuse counseling.
The news comes at a critical time for the Utah franchise, which is looking to establish a competitive roster in its inaugural season. Crouse, expected to be a key top-six forward, now leaves a significant gap in the lineup if suspended.
Team officials released a brief statement: “We are aware of the situation and are working closely with the league. Our priority is supporting Lawson while upholding the integrity of the game.”
Crouse’s agent has yet to comment, but sources suggest they may appeal the test results, citing potential procedural errors or contamination. Meanwhile, fans and analysts are debating the long-term impact on Crouse’s career, as failed drug tests often carry lasting stigma in professional sports.
If suspended, Utah could explore contract voidance or seek salary cap relief, though the NHLPA would likely challenge any extreme measures. For now, the hockey world awaits the league’s official ruling—and whether one of Utah’s key players will be sidelined when the season begins.
